Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
Jan 10, 2012 terifay robert j Officer Automatic Sell 10,981 73.92
Jul 26, 2011 powchik peter Officer Automatic Sell 10,977 54.74 - 55.19
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Oct 5, 2009 vagelos p roy Director Disposition (Non Open Market) 10,796 n/a
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Mar 21, 2011 mccorkle douglas s Officer Automatic Sell 10,600 40.02
Mar 21, 2011 mccorkle douglas s Officer Option Execute 10,600 20.32
Aug 20, 2008 roberts william Officer Disposition (Non Open Market) 10,582 21.40
Dec 17, 2012 yancopoulos george Officer Option Execute 10,369 109.29
Dec 19, 2012 powchik peter Officer Automatic Sell 10,356 176.79 - 183.13
Sep 30, 2008 stahl neil Officer Sell 10,317 21.50 - 22.15
Feb 17, 2011 goldberg murray a Officer Automatic Sell 10,281 37.78
Nov 21, 2012 terifay robert j Officer Disposition (Non Open Market) 10,255 173.83
Mar 22, 2010 aberman michael s Officer Acquisition (Non Open Market) 10,000 n/a
Feb 15, 2008 baker charles a Director Automatic Sell 10,000 18.67 - 19.06
Feb 15, 2008 baker charles a Director Option Execute 10,000 7.91
Feb 20, 2009 baker charles a Director Automatic Sell 10,000 18.16
Feb 20, 2009 baker charles a Director Option Execute 10,000 7.66
Nov 5, 2007 brown michael s Director Option Execute 10,000 7.91
Showing 361-380 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)